Home › Prediabetes › NCT06995378
Study EHR Risk Stratification Tools
Evaluation of Patient and Provider Facing EHR-embedded Risk Stratification Tools
Who can join
Ages 65 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 65 years or older * Hemoglobin A1c in the prediabetes range (5.7- but not including 6.0%) Exclusion Criteria: * Have lab results outside the defined inclusion range * No UCLA primary care provider * Age \<65 years * Eligibility for Surveys: All randomized participants are eligible to receive study surveys. No additional eligibility criteria apply for survey participation. HgbA1c of 6.0 or above is not eligible.
About the study
This study evaluates whether adding machine learning-based risk information to electronic health record (EHR) lab result messages helps older adults better understand their risk of developing diabetes and influences their emotional responses, quality of life, and healthcare use.
Eligible participants are adults aged 65 years and older with a UCLA primary care provider and a hemoglobin A1c level in the range (5.7-6.0%). Participants are identified automatically at the time their lab results are processed and are randomly assigned to receive either standard lab result messages or modified messages that include a "very low risk" label generated by a machine learning model.
All participants who are randomized are invited to complete two surveys: one shortly after their lab result is posted in MyChart and a follow-up survey approximately 30 days later. The study also uses de-identified EHR data to examine patterns of healthcare utilization and progression to diabetes. Provider comments related to lab result messaging will be analyzed to explore differences in response patterns between the two groups.
What is being tested
- Hemoglobin A1c Lab Result Communication Tool (device)
Sponsor: University of California, Los Angeles · Participants: 1,200 · Started: May 27, 2026
Contact the study team
- Katelyn Nguyen Assistant Clinical Research Coordinator · Phone: 310-267-5250
Official record on ClinicalTrials.gov — NCT06995378
Locations in the U.S.
| California | UCLA Health System, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.